What is Achieve Life Sciences's other?

Achieve Life Sciences (ACHV) reported other of -$0 in Q4 2025.

How has Achieve Life Sciences's other changed year-over-year?

Achieve Life Sciences's other increased by 28.6% year-over-year, from -$0 to -$0.

What is the long-term trend for Achieve Life Sciences's other?

Over 2 years (2023 to 2025), Achieve Life Sciences's other has grown at a 11.8% compound annual growth rate (CAGR), from -$0 to -$0.01.

Achieve Life Sciences ACHV Other

Other at other companies

Devon EnergyDVN

0%—

American International GroupAIG

0.5%+0.2pp

IBEX LimitedIBEX

0.2%-0.8pp

Oruka Therapeutics, Inc.ORKA

-0.1%0.0pp

EyePoint, Inc. EYPT

-0.3%-1.2pp

General MotorsGM

-$4.5M—

Other financials

Income statement

See full

Net income-$10.2M+20.7%

EPS (diluted)-$0.19+48.6%

Balance sheet

See full

Cash & equivalents$28.1M+116%

Total debt$5.6M+332%

Total equity$10.7M+3.9%

Total assets$33.1M+21.0%

Cash flow

See full

Operating cash flow-$6.9M+37.5%

CapEx$750.0—

Free cash flow-$12.4M—

Valuation

See full

Market cap$585.16M+404%

Enterprise value$562.71M+439%

Returns & leverage

See full

Return on equity-496.1%-906pp

Debt / equity0.5×+0.4×

Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther.

The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Achieve Life Sciences's other?: Achieve Life Sciences (ACHV) reported other of -$0 in Q4 2025.
How has Achieve Life Sciences's other changed year-over-year?: Achieve Life Sciences's other increased by 28.6% year-over-year, from -$0 to -$0.
What is the long-term trend for Achieve Life Sciences's other?: Over 2 years (2023 to 2025), Achieve Life Sciences's other has grown at a 11.8% compound annual growth rate (CAGR), from -$0 to -$0.01.